Afuco™ Anti-Human LPA ADCC Therapeutic Antibody (LT3000), ADCC Enhanced
Anti-LPA ADCC Enhanced Antibody (LT3000) is an ADCC enhanced antibody produced by our Afuco™ platform. LT3000 is a novel antibody targeting Lysophosphatidic Acid, or LPA, a bioactive lipid that has been characterized in the scientific literature as playing a key role in nerve injury and neuropathic pain.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-477CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | LPA |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |